載入...
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
The vascular endothelial growth factor (VEGF) pathway is a clinically validated antiangiogenic target for non-small cell lung cancer (NSCLC). However, some contradictory results have been reported on the biological effects of antiangiogenic drugs. In order to evaluate the efficacy of these drugs in...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Backwell Publishing Ltd
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3992079/ https://ncbi.nlm.nih.gov/pubmed/24500694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201303214 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|